Ian Chiang

Ian Chiang


Flare Capital Partners


Ian is a Partner at Flare Capital Partners. Ian co-led the firm’s investments into and is currently/formerly on the boards of Inbound Health (Director), knownwell (Director), RightMove (Director), Cayaba Care (Observer), and Oshi Health (Observer), as well as Flare Scholar Ventures investments EarlyBird Education (Observer), Adni, and Vincere Health (Observer).

Prior to joining Flare Capital, Ian served as a Senior Vice President and a founding member of CareAllies, Cigna’s family of multi-payer provider services, population health management, and home-based care businesses. In that capacity, he was responsible for developing new technology-enabled services, evolving existing solutions and service lines, and providing ongoing product management across CareAllies’ businesses. In addition, he was also responsible for developing inorganic strategies for CareAllies since its inception. Before launching CareAllies, Ian held a leadership position with Cigna’s US Strategic Operations team. Ian was a co-founder of several start-ups, including XcelDx, which ultimately partnered with Scanwell Health, a smartphone-enabled diagnostics company backed by Y-Combinator, Founders Fund, DCM, Version One, and Mayfield. He focused his efforts on product development and serve as an advisor to the company. Scanwell was acquired by BD (Becton, Dickinson and Company) in 2021. He also worked for Becton, Dickinson & Company, where he led new product innovation and development. He continues to actively advise and mentor a number of innovative healthcare start-ups.

He started his career at McKinsey & Company and spent five years advising healthcare clients globally. Ian serves as an advisor and board member of various organizations. He is currently a member of the Board of Directors at Harvard Business School Healthcare Alumni Association and served as the 2021 Annual Conference Co-Chair. Additionally, Ian is the Co-Chair of Cornell Tech’s Behavioral Health Next Summit.

Ian has a Bachelor of Science degree in biological engineering from Cornell University, where he graduated with honors and was a Cornell Presidential Research Scholar. He also holds an MBA from Harvard Business School.